Document is current
Any future updates will be listed below
-
Authors
Vasileva, Anastasiia https://orcid.org/0000-0002-5915-9265
Wu, Joyce K. Y. https://orcid.org/0000-0002-4113-2531
Valaee, Melissa https://orcid.org/0009-0004-7389-9800
Ortiz, Ethan https://orcid.org/0009-0006-3772-4039
Hantos, Zoltán https://orcid.org/0000-0002-5696-7750
Tile, Lianne
Ho, Irene
Cheung, Angela M. https://orcid.org/0000-0001-8332-0744
Chow, Chung-Wai https://orcid.org/0000-0001-9344-8522
-
Funding
Funding for this research was provided by:
University of Toronto Pettit Block Term Grant
Hungarian Scientific Research Fund (128701)
- License Information
-
More Information
Article History
Received: 4 January 2025
Accepted: 30 May 2025
First Online: 1 July 2025
Declarations
:
: This study was approved by the University Health Network (UHN) Research Ethics Board (#19–5582 and 17–5652). The participants provided their written informed consent to participate in this study.
: Not applicable.
: AMC: consultant fees Ipsen, grants to UHN from Ipsen and Incyte for the clinical trials in FOP; CWC: speaker honoraria from AstraZeneca Canada and Covis Pharma, investigator-initiated research grant from Thorasys Thoracic Medical Devices Corp. (held at UHN); JW: speaker honoraria from Covis Pharma; consultant fees from Thorasys Thoracic Medical Devices Corp; ZH: consultant fees from Thorasys Thoracic Medical Devices Corp and Piston Medical Ltd.
